Court records from this summer revealed that transvaginal mesh manufacturer Bard knew that they were manufacturing their mesh out of plastic that was not suitable for implantation in humans.  The medical device manufacturer had been told as much by the suppliers of the plastic resin, Chevron Phillips Chemical Company.  Chevron clearly warned Bard that the…

On August 21, 2013, the same day the second trial regarding Bard’s transvaginal mesh product Avaulta was to begin, Bard settled the case for an undisclosed amount. The case was Queen v. C.R. Bard, Inc., in which husband and wife plaintiffs Greg and Wanda Queen alleged that Bard’s Avaulta product caused permanent injury and pain…

In an important verdict against transvaginal mesh manufacturer C.R. Bard, a federal jury in West Virginia found the manufacturer liable for $2 million in damages to a woman who suffered serious injuries after being implanted with a product from its Avaulta line of transvaginal mesh.  The jury deliberated over 2 days, and finally awarded Donna…

  In July 2012, a California jury granted Christine Scott and her husband $5.5 million in medical expenses, pain and suffering, and other damages.  Manufacturer C.R. Bard was found responsible for 60% of this amount, the rest falling to Scott’s doctor, who was not a defendant in the case.   C.R. Bard, based in Murray…